Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin to Prevent Cardiac Dysfunction in Preeclampsia
NCT04479072Phase 4Recruiting
- Sponsor
- University of Chicago
- Start
- Feb 2021
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in preeclampsia, sponsored by University of Chicago. Started Feb 2021; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04479072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479072.